VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER)
Clinical trial NCT05158517 · UNKNOWN
Trial details
- NCT number
- NCT05158517
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-20
- Primary completion
- 2024-03-31
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.